Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus
about
Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infantsIbuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infantsSurgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infantsIbuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infantsIbuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infantsSurgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infantsIbuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infantsIndomethacin for asymptomatic patent ductus arteriosus in preterm infantsEvidence-based use of indomethacin and ibuprofen in the neonatal intensive care unitComparison of renal effects of ibuprofen versus indomethacin during treatment of patent ductus arteriosus in contiguous historical cohorts.New developments in psychopharmacology of attention deficit hyperactivity disorder.Pharmacological Closure of Patent Ductus Arteriosus: Selecting the Agent and Route of Administration.Multiple courses of indomethacin and neonatal outcomes in premature infants.The light still shines, but not that brightly? The current status of perinatal near infrared spectroscopyThe Association between Patent Ductus Arteriosus and Perinatal Infection in A Group of Low Birth Weight Preterm Infants.Effect of early targeted indomethacin on the ductus arteriosus and blood flow to the upper body and brain in the preterm infantShould we definitively abandon prophylaxis for patent ductus arteriosus in preterm new-borns?Patent ductus arteriosus in premature neonates.Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all?Limited effects of intravenous paracetamol on patent ductus arteriosus in very low birth weight infants with contraindications for ibuprofen or after ibuprofen failure.Clinical experience with intravenous Ibuprofen lysine in the pharmacologic closure of patent ductus arteriosus.Pharmacoeconomics of Surgical Interventions vs. Cyclooxygenase Inhibitors for the Treatment of Patent Ductus Arteriosus.Recent advances in neonatal pharmacotherapy.Conservative treatment for patent ductus arteriosus in the preterm.Ibuprofen lysine for the prevention and treatment of patent ductus arteriosus.Nonsteroidal anti-inflammatory administration and patent ductus arteriosus ligation, a survey of practice preferences at US children's hospitals.Patent ductus arteriosus in preterm infants: do we have the right answers?Therapeutic closure of the ductus arteriosus: benefits and limitations.Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis?Current evidence on the safety profile of NSAIDs for the treatment of PDA.The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infants.Cerebral vascular regulation and brain injury in preterm infants.Current research suggests that the future looks brighter for cerebral oxygenation monitoring in preterm infants.Ibuprofen Versus Indomethacin for Medical Closure of the Patent Arterial Duct: A Pooled Analysis by Route of AdministrationThe persistently patent arterial duct in the premature infant.Pharmacologic, pharmacodynamic, and pharmacokinetic considerations with intravenous Ibuprofen lysine.Development of a combined broadband near-infrared and diffusion correlation system for monitoring cerebral blood flow and oxidative metabolism in preterm infantsClinical considerations for the pharmacologic management of patent ductus arteriosus with cyclooxygenase inhibitors in premature infants.Ibuprofen lysine (NeoProfen) for the treatment of patent ductus arteriosus.Preservation of the metabolic rate of oxygen in preterm infants during indomethacin therapy for closure of the ductus arteriosus.
P2860
Q24188100-6CA66288-3788-4499-B8E1-F483EE787AF5Q24197958-2AC644A1-E305-4057-8FDF-33A831E04329Q24198805-093EDE2C-53D5-443D-A08B-EFF276BF45E1Q24235550-16B8C215-CEF7-403C-8574-9496D5183DAFQ24235778-D05D5990-C12B-414F-AD72-A2EBEA55373EQ24242627-8E733801-7E08-4E6D-923C-FE4CD3E3BE0DQ24244935-CD3E40C9-0C35-4410-A0C5-DB999F82FA66Q24250190-2313AA44-C02C-4054-8CAC-4963AD7B23C7Q24604121-07786348-5AC6-4758-8523-8D295348C19BQ33947204-DB43B94A-569E-4540-8A5C-3A1115D359B6Q34481761-C626A6DB-26EA-482A-B48B-DD47552ECBB1Q34517223-114F2E6E-A304-40DF-9BCF-8581BCAC2CDBQ34846689-9A7A1C68-C284-47C2-86E7-B2CEEC105D1BQ35159320-39CE023D-6D6E-46D5-A446-CFC4144475B7Q35177310-033FED49-DDA9-4E9E-831A-16EE09585677Q35571728-959DFD59-6A45-4D9D-BC03-63A534722BA9Q35580251-88FCB714-4A95-412B-B92A-2536EA3C9490Q35607990-41267DA7-08A6-4FB2-A757-7805E12156D2Q35834962-815F604F-16BC-451B-853B-BD39D77A2CE4Q36214850-192829D6-D950-4AD9-B520-2CFB05E1F0D6Q36290884-572C1B40-74D1-4CF2-BFFC-6F0B4A6E96BEQ36290893-E9EFF951-D50C-4C92-A6B5-3C66FA5E8FBCQ36434300-F11A5A26-A015-4855-90C2-002D44DBC2F3Q37174836-19B417D3-9FF8-4FC2-B0FF-E8396971A68FQ37254466-DF8F3A42-FC68-4B88-B4B2-0F6271471121Q37324451-F26752BF-73B6-4B8E-938E-092594F2AADDQ37451050-54AE6B5F-E8AA-4495-AB92-FDB0FCB01EAFQ37635171-61CCA7D4-A2A8-4ABE-9AEE-608F19FCA592Q37698200-EAA062C6-BBCA-46F8-BA3D-A84E18053387Q37900320-5ECF6489-0862-46B5-BD20-CE945CDCA122Q38127117-72027432-EB42-4920-9356-88CE0543FB65Q38197506-4C9E4421-8F61-432C-A212-8CD8A9896D4EQ38306914-08398EE2-4B14-49E8-B79D-FE264B0C459FQ38548285-211971B0-32B3-4FC2-9D6A-F5BA3943B720Q39652304-7C98FF14-2D3E-4B13-8F71-C421C22AC69EQ40199090-0C4D949B-096F-40B5-BF35-04CC174109A6Q42177149-7EC9D003-DC10-4DA3-80B4-339A28E2A713Q42534997-69B28B93-394D-4112-9B30-8C5927980E23Q43011724-AA6EDB61-9896-4265-8883-5C11DEACDBCBQ43655741-E3A09472-E135-4599-B829-22C02F09AB88
P2860
Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Randomized double-blind contro ...... with patent ductus arteriosus
@ast
Randomized double-blind contro ...... with patent ductus arteriosus
@en
Randomized double-blind contro ...... with patent ductus arteriosus
@nl
type
label
Randomized double-blind contro ...... with patent ductus arteriosus
@ast
Randomized double-blind contro ...... with patent ductus arteriosus
@en
Randomized double-blind contro ...... with patent ductus arteriosus
@nl
prefLabel
Randomized double-blind contro ...... with patent ductus arteriosus
@ast
Randomized double-blind contro ...... with patent ductus arteriosus
@en
Randomized double-blind contro ...... with patent ductus arteriosus
@nl
P2093
P2860
P1433
P1476
Randomized double-blind contro ...... with patent ductus arteriosus
@en
P2093
P2860
P356
10.1203/00006450-200001000-00009
P407
P577
2000-01-01T00:00:00Z
P6179
1064217169